cisapride has been researched along with Gastritis in 4 studies
Cisapride: A substituted benzamide used for its prokinetic properties. It is used in the management of gastroesophageal reflux disease, functional dyspepsia, and other disorders associated with impaired gastrointestinal motility. (Martindale The Extra Pharmacopoeia, 31st ed)
cisapride : The amide resulting from formal condensation of 4-amino-5-chloro-2-methoxybenzoic acid with cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-amine. It has been used (as its monohydrate or as its tartrate) for the treatment of gastro-oesophageal reflux disease and for non-ulcer dyspepsia, but its propensity to cause cardiac arrhythmias resulted in its complete withdrawal from many countries, including the U.K., and restrictions on its use elsewhere.
Gastritis: Inflammation of the GASTRIC MUCOSA, a lesion observed in a number of unrelated disorders.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In the present double-blind placebo-controlled study the effect of cisapride on functional dyspepsia was evaluated in patients with and without histological gastritis." | 9.08 | Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial. ( Chintana-Wilde, W; Choo, HF; Gwee, KA; Kang, JY; Tan, CC; Tay, HH; Teh, M; Wee, A; Yeoh, KG, 1997) |
| "In order to evaluate the symptomatic efficacy of cisapride on motility disorders often associated with mild inflammatory changes of the upper gastrointestinal tract, the authors carried out a comparison between two groups of patients (15 patients in each group, 10 males and 5 females) with histologic antral gastritis, treated respectively with famotidine 40 mg/day per os plus cisapride 10 mg ter/die per os, and famotidine alone." | 7.69 | [Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis]. ( Dallera, F; Gendarini, A; Scanzi, G, 1994) |
| "In the present double-blind placebo-controlled study the effect of cisapride on functional dyspepsia was evaluated in patients with and without histological gastritis." | 5.08 | Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial. ( Chintana-Wilde, W; Choo, HF; Gwee, KA; Kang, JY; Tan, CC; Tay, HH; Teh, M; Wee, A; Yeoh, KG, 1997) |
| "In order to evaluate the symptomatic efficacy of cisapride on motility disorders often associated with mild inflammatory changes of the upper gastrointestinal tract, the authors carried out a comparison between two groups of patients (15 patients in each group, 10 males and 5 females) with histologic antral gastritis, treated respectively with famotidine 40 mg/day per os plus cisapride 10 mg ter/die per os, and famotidine alone." | 3.69 | [Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis]. ( Dallera, F; Gendarini, A; Scanzi, G, 1994) |
| "Cisapride was well tolerated and thus appears to be a useful option in the treatment of functional digestive disorders in a general practice setting." | 1.29 | Functional dyspepsia versus other functional gastrointestinal disorders: a practical approach in Belgian general practices. ( Cardon, E; Jaecques, N; Lebrun, F; Meurant, JP; Rombouts, J; Spaepen, W; Verhaeghe, J, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dallera, F | 1 |
| Scanzi, G | 1 |
| Gendarini, A | 1 |
| Verhaeghe, J | 1 |
| Jaecques, N | 1 |
| Rombouts, J | 1 |
| Spaepen, W | 1 |
| Cardon, E | 1 |
| Lebrun, F | 1 |
| Meurant, JP | 1 |
| Yeoh, KG | 1 |
| Kang, JY | 1 |
| Tay, HH | 1 |
| Gwee, KA | 1 |
| Tan, CC | 1 |
| Wee, A | 1 |
| Teh, M | 1 |
| Choo, HF | 1 |
| Chintana-Wilde, W | 1 |
| Chen, R | 1 |
| Kang, M | 1 |
2 trials available for cisapride and Gastritis
| Article | Year |
|---|---|
Effect of cisapride on functional dyspepsia in patients with and without histological gastritis: a double-blind placebo-controlled trial.
Topics: Adult; Anti-Ulcer Agents; Cisapride; Double-Blind Method; Dyspepsia; Female; Gastric Mucosa; Gastrit | 1997 |
Observation on frequency spectrum of electrogastrogram (EGG) in acupuncture treatment of functional dyspepsia.
Topics: Acupuncture Therapy; Adult; Cisapride; Dyspepsia; Electrophysiology; Female; Gastritis; Gastrointest | 1998 |
2 other studies available for cisapride and Gastritis
| Article | Year |
|---|---|
[Prokinetic activity and antral inflammation. Usefulness of cisapride combined with H2 antagonists in gastritis].
Topics: Anti-Ulcer Agents; Cisapride; Drug Therapy, Combination; Famotidine; Female; Gastritis; Gastrointest | 1994 |
Functional dyspepsia versus other functional gastrointestinal disorders: a practical approach in Belgian general practices.
Topics: Adult; Aged; Belgium; Cisapride; Cluster Analysis; Constipation; Dyspepsia; Family Practice; Female; | 1993 |